Bejelentkezés Regisztrálj ingyen

Adma Biologics Inc Quick ratio

Mi az Adma Biologics Inc Quick ratio?

A Quick ratio az Adma Biologics Inc - 2.80

Mi a Quick ratio meghatározása?



A gyors arány a likviditási mutató, amely a vállalat azon képességét méri, hogy a gyors eszközeit azonnal felhasználhassa rövid távú kötelezettségeinek teljesítéséhez.

The quick ratio is the ratio between quick or liquid assets and current liabilities. Quick assets include those current assets that presumably can be quickly converted to cash at close to their book values. A normal liquid ratio is considered to be 1. A company with a quick ratio of less than 1 cannot at the time fully pay its current liabilities or short-term obligations. This ratio is considered to be a much reliable tool for assessment of liquidity position of companies.

Quick ratio a Health Care szektor a NASDAQ-on cégekben a Adma Biologics Inc -hoz képest

Mit csinál Adma Biologics Inc?

adma is a late-stage biopharmaceutical company that develops, manufactures and intends to commercialize specialty plasma-based biologics for the treatment and prevention of primary immune deficiency disease (pidd) and certain infectious diseases. adma's mission is to develop and commercialize plasma-derived, human immune globulins targeted to niche patient populations for the treatment and prevention of certain infectious diseases. the target patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease, or who may be immune-compromised for medical reasons. adma’s lead product candidate, ri-002, has completed a phase iii clinical trial in patients with pidd and has met the primary endpoint. a bla for ri-002 was accepted by the fda on september 18, 2015. the company has received u.s. patent 9,107,906. for more information, please visit the company's website at www.admabiologics.com.

quick ratio -hoz hasonló cégek Adma Biologics Inc